US Begins First Human Trial of Coronavirus Vaccine
The first human trial to evaluate a candidate vaccine against coronavirus disease 2019 has begun in Seattle, US health officials said today.
“The open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks,” the US National Institutes of Health (NIH) said in a statement.
“The first participant received the investigational vaccine today.”
But the candidate would still need to progress through various more stages, known as phases, to prove it works and is safe.
US officials have estimated it may take another year to 18 months before it becomes available — if everything goes to plan.
The vaccine is called mRNA-1273 and was developed by NIH scientists and collaborators at biotechnology company Moderna, which is based in Cambridge, Massachusetts.
Funding was also provided by the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI).
“The open-label trial will enroll 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks,” the US National Institutes of Health (NIH) said in a statement.
“The first participant received the investigational vaccine today.”
But the candidate would still need to progress through various more stages, known as phases, to prove it works and is safe.
US officials have estimated it may take another year to 18 months before it becomes available — if everything goes to plan.
The vaccine is called mRNA-1273 and was developed by NIH scientists and collaborators at biotechnology company Moderna, which is based in Cambridge, Massachusetts.
Funding was also provided by the Oslo-based Coalition for Epidemic Preparedness Innovations (CEPI).
Posted in World News
Related
More Than 12 Valencia Players, Staff Test Positive To Coronavirus
Saudi Arabia Orders Workers to Stay at Home, Closes Malls
Spain Records New 1000 Coronavirus Cases Within 24 Hours
21 Year Old Fooballer, Francisco Garcia Killed By Coronavirus
Popular Iranian Cleric, Ayatollah Bathaei Dies of Coronavirus
Promoted Contents
No comments